factors and other disease modifying anti-rheumatic drugs (DMARDs) is published in JSP 950 6-7-6. This has just been reviewed and advises that patients on DMARDs should be graded no higher than Medically Limited Deployability. 4 However, the readership should be aware that this can vary between the Single Services. Clinicians are therefore advised to refer these patients to the Regional Occupational Health Team for advice about management. Currently, Army Occupational Medicine would advise a grading of no higher than P7 MLD for the majority of these patients. 
